REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,515 | -54.7% | 132 | 0.0% | 0.00% | – |
| Q2 2023 | $3,342 | -76.0% | 132 | -69.4% | 0.00% | – |
| Q1 2023 | $13,916 | +74.5% | 432 | 0.0% | 0.00% | – |
| Q4 2022 | $7,975 | -33.5% | 432 | 0.0% | 0.00% | – |
| Q3 2022 | $12,000 | +140.0% | 432 | +23.1% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 351 | -4.6% | 0.00% | – |
| Q1 2022 | $7,000 | -68.2% | 368 | -72.3% | 0.00% | – |
| Q4 2021 | $22,000 | +120.0% | 1,327 | +278.1% | 0.00% | – |
| Q3 2021 | $10,000 | +11.1% | 351 | +17.0% | 0.00% | – |
| Q2 2021 | $9,000 | +12.5% | 300 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | -11.1% | 300 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |